Healthcare [ 7/13 ] | Biotechnology [ 82/163 ]
NASDAQ | Common Stock
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases.
Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities.
The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA.
The company is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 24 | -0.83 Decreased by -934.38% | - |
| Oct 12, 23 | 0.00 Increased by +100.00% | -0.60 Increased by +100.00% |
| Sep 29, 23 | 0.00 Increased by +100.00% | -1.20 Increased by +100.00% |
| May 1, 23 | -0.08 Increased by +34.21% | -0.04 Decreased by -100.00% |
| Mar 30, 23 | -0.08 Decreased by -156.41% | -0.07 Decreased by -14.29% |
| Dec 30, 22 | -0.04 Increased by +73.65% | -0.04 |
| Sep 27, 22 | -0.10 Decreased by -866.00% | - |
| May 16, 22 | -0.12 Decreased by -380.83% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 0.00 Decreased by N/A% | -5.57 M Decreased by -656.04% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | N/A Decreased by N/A% | -3.50 M Decreased by -1.71% | - - |
| Sep 30, 23 | N/A Decreased by N/A% | -3.50 M Decreased by -1.71% | - - |
| Jun 30, 23 | 0.00 Decreased by N/A% | -3.00 M Increased by +45.89% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | 1.00 M Increased by +119.59% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 22 | N/A Decreased by N/A% | -3.45 M Increased by +38.61% | - - |
| Sep 30, 22 | N/A Decreased by N/A% | -3.45 M Decreased by -141.80% | - - |
| Jun 30, 22 | 0.00 Decreased by N/A% | -5.54 M Decreased by -26.70% | Decreased by N/A% Decreased by N/A% |